Government funds Ebola, Marburg vaccine

The federal government has granted researchers at Emory, the Georgia Institute of Technology and Texas Biomed a $5.4 million grant to further develop a vaccine against Ebola and Marburg hemorrhagic. The shot, which uses parts of the virus to elicit immunity, has already been tested in rats and will now be studied in nonhuman primates. Article

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.